Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Evinquo Launches Advanced Risk Management System for Real-Time Exposure Monitoring
-
Director/PDMR Shareholding
-
DeepMarkit Clarifies Market Maker Engagement Terms and U.S. Trading Symbol
-
Argo Graphene Solutions Reports 56-Day Compressive Strength Test Confirms 25% Total Increase in Graphene-Infused Concrete
-
F3 Announces High Grade Domain of 10.8 M lbs. at 12.23% U3O8 at JR Zone Uranium Deposit Within an 11.8 M lbs. at 4.39% U3O8 Initial Indicated Mineral Resource
-
Sri Lanka and the Middle East's top real estate achievements recognised at 2025 PropertyGuru Asia Property Awards
-
Repurchase of Truecaller B shares in week 51, 2025
-
Structure Law Group, LLP Expands Los Angeles Litigation Practice with Addition of Business Litigation Attorney Chris Tarpley
-
Papercast announces leadership transition as it enters next chapter of growth and global expansion
-
XRP Healthcare® Secures Global Trademark Protection at the Intersection of Healthcare Services and XRP-Powered Payments
-
Beko Secures €100 Million Sustainability-Linked Loan from IFC to Drive Global Innovation and Net-Zero Transformation
-
Menarini Silicon Biosystems announces PACE trial biomarker analysis results confirming clinical utility of CELLSEARCH® CTC enumeration to guide treatment decisions in a specific metastatic breast can
-
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor
-
KKR Launches European Rail Leasing Platform with Green Mobility Partners
-
Kalmar to relocate and modify two STS cranes for Eurogate’s Wilhelmshaven terminal
-
Reporting calendar in 2026
-
Seize the Christmas Market Opportunities, Vince Trust Launches Bitcoin ETF Portfolio, Offering Daily Returns of Up to $3,548
-
Meximodo Tequila Announces Launch of Meximodo Tequila Blanco, a Woman-Led Organic Tequila Brand
-
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma
-
Incyte Japan Announces Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Anal Cancer
-
SKF achieves prestigious CDP 'A' Score for Environmental Leadership
-
ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer
-
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer
-
GBC AG Analyst Coverage Report on Mexedia S.p.A. Società Benefit Completed and Published
-
ArcelorMittal expands its portfolio of renewable energy projects
-
L&D Tech Selected as a World-Class Product with Its Energy-Saving LED Display; Receives Prime Minister's Award and Announces Global Launch
-
Justin Jeansonne An Emerging Country Singer-Songwriter Music Fans Have Been Waiting For…a True Maverick
-
Karolinska Development’s portfolio company SVF Vaccines plans for listing on Nasdaq First North Premier through reverse takeover ahead of accelerated vaccine development
-
Skanska divests two office buildings in Copenhagen, Denmark, for DKK 1.0 billion, about SEK 1.5 billion
-
Mondego Bio Announces Selection of a PTPN2 Inhibitor Clinical Candidate and Targets First-in-Human Trials in H1 2026
-
Pantheon Resources PLC Announces Shareholder Letter and Corporate Update on Dubhe-1
-
Tocvan Begins Trenching Material for the Pilot Mine and Pushes Ahead With Infrastructure Development
-
Thor Explorations Announces Douta Project Preliminary Feasibility Study Release Date
-
Transaction in Own Shares
-
JAB Insurance to Enter UK Life and Pension Market With Acquisition of Utmost Group’s Life and Pensions Business
-
Coty Appoints Markus Strobel Executive Chairman and Interim CEO
-
Cloudfresh Wins 2025 EMEA GitLab Partner of the Year Award for Emerging Markets in Eastern Europe and Israel
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 3)
-
Report on the audited financial performance of the bank during the nine month of 2025
-
NBPE Announces Transaction in Own Shares
-
Holding(s) in Company
-
OSB GROUP PLC - Transaction in Own Shares
-
A.P. Moller Capital announces Indian renewables investment with Rays Power Infra
-
Alvotech announces European launch of first-in-market biosimilar to Simponi® (golimumab) globally by partner Advanz Pharma
-
SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY
-
THEON concludes a transformative 2025
-
EQT to acquire A-Train, operator of Arlanda express - the high-speed rail link connecting Stockholm with Arlanda Airport
-
Cytranet Announces Expansion: New Fiber Optic Network to Serve Southern California
-
Russellville Huntington Learning Center Expands Access to Literacy Support; Approved Provider Under Arkansas Department of Education
-
Connecting with the Knoxville Community

